Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Mittapalli, Rajendar K.
82  Ergebnisse:
Personensuche X
?
1

Translation of nonclinical to clinical safety findings for ..:

Leach, Michael W. ; Rana, Payal ; Hu, Wenyue...
Toxicology and Applied Pharmacology.  484 (2024)  - p. 116854 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Oncology Combination Dose‐Finding Study Design for Targeted..:

Zhou, Li ; Reddy, Micaela B. ; Mittapalli, Rajendar K...
Clinical Pharmacology & Therapeutics.  115 (2023)  1 - p. 29-35 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Oncology dose optimization paradigms: knowledge gained and ..:

Mittapalli, Rajendar K. ; Guo, Cen ; Drescher, Stefanie K..
Cancer Chemotherapy and Pharmacology.  90 (2022)  3 - p. 207-216 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Assessment of the Utility of Physiologically-based Pharmaco..:

Yu, Yanke ; Lin, Jian ; Muto, Chieko...
International Journal of Medical Sciences.  18 (2021)  16 - p. 3718-3727 , 2021
Link: https://doi.org/10.7150/..
 
?
5

Starting dose selection and dose escalation for oncology sm..:

Mittapalli, Rajendar K. ; Yin, Donghua ; Beaupre, Darrin.
Cancer Chemotherapy and Pharmacology.  87 (2020)  1 - p. 23-30 , 2020
Link: https://doi.org/10.1007/..
 
?
6

An Integrated Population Pharmacokinetic Model Versus Indiv..:

Mittapalli, Rajendar K. ; Stodtmann, Sven ; Friedel, Anna...
The Journal of Clinical Pharmacology.  59 (2019)  9 - p. 1225-1235 , 2019
Link: https://doi.org/10.1002/..
 
?
7

Population Pharmacokinetics of Upadacitinib Using the Immed..:

Klünder, Ben ; Mittapalli, Rajendar K. ; Mohamed, Mohamed-Eslam F....
Clinical Pharmacokinetics.  58 (2019)  8 - p. 1045-1058 , 2019
Link: https://doi.org/10.1007/..
 
?
8

Efficacy and safety results of depatuxizumab mafodotin (ABT..:

Goss, Glenwood D. ; Vokes, Everett E. ; Gordon, Michael S....
Cancer.  124 (2018)  10 - p. 2174-2183 , 2018
Link: https://doi.org/10.1002/..
 
?
9

A phase 1 study of PARP-inhibitor ABT-767 in advanced solid..:

van der Biessen, Diane A. J. ; Gietema, Jourik A. ; de Jonge, Maja J. A....
Investigational New Drugs.  36 (2018)  5 - p. 828-835 , 2018
Link: https://doi.org/10.1007/..
 
?
10

Population pharmacokinetics of ABT-767 in BRCA1 or BRCA2 mu..:

Mittapalli, Rajendar K. ; Nuthalapati, Silpa ; Shepherd, Stacie Peacock.
Cancer Chemotherapy and Pharmacology.  79 (2017)  3 - p. 587-594 , 2017
Link: https://doi.org/10.1007/..
 
?
11

Development of In Vitro-In Vivo Correlation for Potassium C..:

Mittapalli, Rajendar K. ; Marroum, Patrick ; Qiu, Yihong..
Pharmaceutical Research.  34 (2017)  7 - p. 1527-1533 , 2017
Link: https://doi.org/10.1007/..
 
?
12

Evaluation of the effect of the EGFR antibody-drug conjugat..:

Munasinghe, Wijith P. ; Mittapalli, Rajendar K. ; Li, Hong...
Cancer Chemotherapy and Pharmacology.  79 (2017)  5 - p. 915-922 , 2017
Link: https://doi.org/10.1007/..
 
?
13

Development of a Level A in Vitro-in Vivo Correlation for V..:

Mittapalli, Rajendar K. ; Nuthalapati, Silpa ; Delke DeBord, Alyssa E..
Pharmaceutical Research.  34 (2017)  6 - p. 1187-1192 , 2017
Link: https://doi.org/10.1007/..
 
?
14

Smoking History Predicts Sensitivity to PARP Inhibitor Veli..:

Reck, Martin ; Blais, Normand ; Juhasz, Erzsebet...
Journal of Thoracic Oncology.  12 (2017)  7 - p. 1098-1108 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Semi-automated rapid quantification of brain vessel density..:

Bohn, Kaci A. ; Adkins, Chris E. ; Mittapalli, Rajendar K....
Journal of Neuroscience Methods.  270 (2016)  - p. 124-131 , 2016
Link: https://doi.org/10.1016/..
 
1-15